CDK9 and esophageal adenocarcinoma: Treatment with the CDK9 inhibitor plus radiation potently retarded the rapid growth of radiation sensitive FLO-1, OE33 xenografts, radiation resistant OE33R xenografts and slowly growing SKGT4 xenografts suggesting that the combination has potent anti-tumorigenic effects in vivo against esophageal adenocarcinoma.